Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
478.54
+7.95 (1.69%)
At close: Mar 9, 2026, 4:00 PM EDT
478.60
+0.06 (0.01%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Medpace Holdings Revenue
In the year 2025, Medpace Holdings had annual revenue of $2.53B with 19.97% growth. Medpace Holdings had revenue of $708.45M in the quarter ending December 31, 2025, with 32.03% growth.
Revenue (ttm)
$2.53B
Revenue Growth
+19.97%
P/S Ratio
5.37
Revenue / Employee
$408,102
Employees
6,200
Market Cap
13.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.53B | 421.18M | 19.97% |
| Dec 31, 2024 | 2.11B | 223.21M | 11.84% |
| Dec 31, 2023 | 1.89B | 425.85M | 29.17% |
| Dec 31, 2022 | 1.46B | 317.62M | 27.80% |
| Dec 31, 2021 | 1.14B | 216.45M | 23.38% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.34B |
| Mettler-Toledo International | 4.03B |
| Charles River Laboratories International | 4.02B |
| Exact Sciences | 3.25B |
| Revvity | 2.86B |
MEDP News
- 19 days ago - Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility - PRNewsWire
- 26 days ago - Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial - GlobeNewsWire
- 4 weeks ago - Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results - Business Wire
- 2 months ago - Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026 - Business Wire
- 3 months ago - 6 Healthcare Stocks With Strong Upward Momentum - Benzinga
- 4 months ago - Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings - Benzinga
- 4 months ago - Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins - Benzinga
- 4 months ago - Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back - Barrons